Effects of Cyclization on Stability, Structure, and Activity of α-Conotoxin RgIA at the α9α10 Nicotinic Acetylcholine Receptor and GABAB Receptor
- 2 September 2011
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 54 (19) , 6984-6992
Abstract
α-Conotoxin RgIA is of interest as a lead in the development of drugs for neuropathic pain. It modulates the α9α10 nicotinic acetylcholine receptor (nAChR) and the GABAB receptor, both of which are implicated in antinociception. However, because of its peptidic nature, RgIA is potentially susceptible to generic problems encountered by peptide-based drugs of poor oral bioavailability, short biological half-life, and low stability. Here, we improved the biopharmaceutical properties of RgIA by backbone cyclization using 3–7 residue peptidic linkers. Cyclization with a six-residue linker does not perturb the overall structure of RgIA, improves selectivity for the GABAB receptor over the α9α10 nAChR, and improves stability in human serum. The results provide insights to further improve the therapeutic properties of RgIA and other conotoxins being considered as drug leads and confirm that cyclization is a readily applicable strategy to improve the stability of peptides with proximate N- and C-termini.Keywords
This publication has 48 references indexed in Scilit:
- Chemical Re-engineering of Chlorotoxin Improves Bioconjugation Properties for Tumor Imaging and Targeted TherapyJournal of Medicinal Chemistry, 2011
- Improving the Stability of α-Conotoxin AuIB Through N-to-C Cyclization: The Effect of Linker Length on Stability and Activity at Nicotinic Acetylcholine ReceptorsAntioxidants & Redox Signaling, 2011
- Functional Characterization of α9-Containing Cholinergic Nicotinic Receptors in the Rat Adrenal Medulla: Implication in Stress-Induced Functional PlasticityJournal of Neuroscience, 2010
- Alpha9 nicotinic acetylcholine receptors and the treatment of painBiochemical Pharmacology, 2009
- Integrating the discovery pipeline for novel compounds targeting ion channelsCurrent Opinion in Chemical Biology, 2008
- α-RgIA, a Novel Conotoxin That Blocks the α9α10 nAChR: Structure and Identification of Key Receptor-Binding ResiduesJournal of Molecular Biology, 2008
- The three‐dimensional structure of the analgesic α‐conotoxin, RgIAFEBS Letters, 2008
- Are α9α10 Nicotinic Acetylcholine Receptors a Pain Target for α-Conotoxins?Molecular Pharmacology, 2007
- Molecular mechanism for analgesia involving specific antagonism of α9α10 nicotinic acetylcholine receptorsProceedings of the National Academy of Sciences, 2006
- Structure determination of the three disulfide bond isomers of α-conotoxin GI: a model for the role of disulfide bonds in structural stability 1 1Edited by P. E. WrightJournal of Molecular Biology, 1998